<DOC>
	<DOCNO>NCT00386087</DOCNO>
	<brief_summary>The purpose study determine effectiveness enzastaurin treatment patient metastatic breast cancer .</brief_summary>
	<brief_title>Enzastaurin For Breast Cancer Patients Who Previously Received Anthracycline Taxane Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Taxane</mesh_term>
	<criteria>Clinical diagnosis metastatic breast cancer recurrent breast cancer surgery do curative intent Have receive prior therapy anthracycline ( class drug ) taxane ( class drug ) . Tumors must positive HER2 , positive , treatment plan include treatment drug Herceptin . Disease definitely measure Cat Scans radiological test . May receive high dose chemotherapy autologous stem cell support great equal 6 month start study . More 2 chemotherapy regimen metastatic locally recurrent disease . Have brain cancer breast cancer Pregnant breastfeeding Have inability swallow tablet Within 6 month serious heart condition</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Cancer Breast</keyword>
</DOC>